logo

For the Inventor, By the Inventor

Warren, NJ, United States of America

Anthrogenesis Corporation


USPTO Granted Patents = 64



Trademarks = 3

Forward Citations = 2,005

Loading Chart...
Loading Chart...

53 inventors (with patents filed for the assignee):

goldMedal Robert J Hariri (43 out of 65 patents)

silverMedal James W Edinger (22 out of 30 patents)

bronzeMedal Qian Ye (16 out of 22 patents)

4.  Mohammad A Heidaran (11 out of 19 patents)

5.  Xiaokui Zhang (10 out of 16 patents)

6.  Jia-Lun Wang (9 out of 13 patents)

7.  Vanessa R Voskinarian-Berse (9 out of 11 patents)

8.  Lin Kang (8 out of 10 patents)

9.  Andrew L Zeitlin (7 out of 26 patents)

10.  Stewart Abbot (6 out of 15 patents)

11.  Kristen S Labazzo (5 out of 8 patents)

12.  Ajai Pal (5 out of 6 patents)

13.  Eric Law (5 out of 7 patents)

14.  Ryhor Harbacheuski (5 out of 5 patents)

15.  RoseAnn Murray (5 out of 5 patents)


Core Competencies:
Placental Stem Cells
Natural Killer Cells
Immunomodulation
Erythrocyte Production
Tumor Suppression
Angiogenesis
Cytotherapeutics
Bone Defect Treatment
Tissue Renovation
Inflammatory Disease Treatment
Placental Tissue Compositions
Umbilical Cord Biomaterial

64 patents:

1. 9770488 - Human placental collagen compositions, and methods of making and using the same (2017-09-26),
2. 9763983 - Natural killer cells from placenta (2017-09-19),
3. 9725694 - Composition for collecting and preserving placental stem cells and methods of using the composition (2017-08-08),
4. 9598669 - Composition for collecting placental stem cells and methods of using the composition (2017-03-21),
5. 9575054 - Identification of antitumor compounds using placenta (2017-02-21),
6. 9539288 - Immunomodulation using placental stem cells (2017-01-10),
7. 9464274 - Methods of generating natural killer cells (2016-10-11),
8. 9387283 - Method of collecting placental stem cells (2016-07-12),
9. 9364585 - Methods for collecting and using placenta cord blood stem cells (2016-06-14),
10. 9339520 - Methods and compositions for treatment of bone defects with placental cell populations (2016-05-17),
11. 9255248 - Method of producing erythrocytes without feeder cells (2016-02-09),
12. 9254302 - Angiogenesis using placental stem cells (2016-02-09),
13. 9216200 - Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells (2015-12-22),
14. 9200253 - Method of producing erythrocytes (2015-12-01),
15. 9149569 - Treatment of diseases or disorders using placental stem cells (2015-10-06),
Anthrogenesis Corporation is a biotechnology company focused on therapeutic applications of stem cells. With expertise in regenerative medicine, Anthrogenesis specializes in the development and commercialization of novel stem cell-based therapies for a range of diseases and conditions. Through strategic partnerships and cutting-edge research, Anthrogenesis aims to advance the field of stem cell science and improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

64 Patents

#5 in Warren, NJ

#239 in New Jersey

#5,446 in US

#11,029 in the World

...
Warren, NJ, United States of America

Anthrogenesis Corporation

Forward Citations = 2,005

53 inventors:

goldMedal Robert J Hariri (43 out of 65 patents)

silverMedal James W Edinger (22 out of 30 patents)

bronzeMedal Qian Ye (16 out of 22 patents)

4.  Mohammad A Heidaran (11 out of 19 patents)

5.  Xiaokui Zhang (10 out of 16 patents)

Please report any incorrect information to support@idiyas.com
Loading…